Reaction Biology located in Freiburg, Germany and Malvern, Pennsylvania is an industry leader and innovator specializing in research services for drug discovery offering a wide range of services, including biochemical, biophysical and cell assay technologies for high-throughput screening and selectivity compound profiling. Our in vivo tumor models are suited to advance conventional and immune-modulating drug candidates.